metotrexato cipla 10 mg comprimidos
cipla europe nv - metotrexato - excipientes: lactosa monohidrato,carboximetilalmidon sodico - inmunosupresores - otros inmunosupresores - metrotexato
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - agentes antineoplásicos - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
tecvayli
janssen-cilag international n.v. - teclistamab - mieloma múltiple - agentes antineoplásicos - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
talvey
janssen-cilag international n.v. - talquetamab - mieloma múltiple - agentes antineoplásicos - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
myfenax 250 mg capsulas duras efg, 100 capsulas
micofenolato mofetilo teva 500 mg comprimidos recubiertos con pelicula efg, 50 compr
myfenax 500 mg comprimidos recubiertos con pelicula efg 50 comprimidos
metotrexato actavis 25 mg/ml solucion inyectable y para perfusion efg
actavis group ptc ehf - metotrexato - excipientes: cloruro de sodio,hidroxido de sodio (e-524),hidroxido de sodio (e-524) - antimetabolitos - análogos del ácido fólico - metotrexato
methocel 50 50mg/2ml solucion inyectable
seven pharma s.a.c. - droguerÍa - metotrexato; - solucion inyectable - por mililitro 2.00 ml - - metotrexato
acido micofenolico ratiopharm 180 mg comprimidos gastrorresistentes efg
ratiopharm españa, s.a. - micofenolato sodio - excipientes: croscarmelosa sodica,hidrogeno carbonato de sodio,laurilsulfato de sodio,propilenglicol - inmunosupresores - inmunosupresores selectivos - Ácido micofenólico